Advertisement

Tsukamurella: an emerging opportunistic ocular pathogen

      This paper is only available as a PDF. To read, Please Download here.

      References

        • Poonwan N
        • Mekha N
        • Yazawa K
        • Thunyaharn S
        • Yamanaka A
        • Mikami Y
        Characterization of clinical isolates of pathogenic Nocardia strains and related actinomycetes in Thailand from 1996 to 2003.
        Mycopathologia. 2005; 159: 361-368
        • Boiron P
        • Provost F
        • Chevrier G
        • Dupont B
        Review of nocardial infections in France 1987 to 1990.
        Eur J Clin Microbiol Infect Dis. 1992; 11: 709-714
        • Stackenbrandt E
        • Rainey F
        • Ward-Rainey N
        Proposal for a new hierarchic classification system, Actinobacteria classis nov.
        Int J Syst Bacteriol. 1997; 47: 479-491
        • Tropis M
        • Lemassu A
        • Vincent V
        • Daffé M
        Structural elucidation of the predominant motifs of the major cell wall arabinogalactan antigens from the borderline species Tsukamurella paurometabolum and Mycobacterium fallax.
        Glycobiology. 2005; 15: 677-686
        • Woo P
        • Ngan A
        • Lau S
        • Yuen K
        Tsukamurella conjunctivitis: a novel clinical syndrome.
        J Clin Microbiol. 2003; 41: 3368-3371
        • Yassin A
        • Rainey F
        • Brzezinka H
        • et al.
        Tsukamurella pulmonis sp. nov..
        Int J Syst Bacteriol. 1996; 46: 429-436
        • Maalouf R
        • Mierau S
        • Moore T
        • Kaul A
        First case report of community-acquired pneumonia due to Tsukamurella pulmonis.
        Ann Intern Med. 2009; 150: 147-148
        • Schwartz M
        • Tabet S
        • Collier A
        • et al.
        Central venous catheter-related bacteremia due to Tsukamurella species in the immunocompromised host: a case series and review of the literature.
        Clin Infect Dis. 2002; 35: 72-77
        • Bouza E
        • Perez-Parra A
        • Rosal M
        • Martin-Rabadan P
        • Rodriguez-Creixems M
        • Marin M
        Tsukamurella: a cause of catheter-related bloodstream infections.
        Eur J Clin Microbiol Infect Dis. 2009; 28: 203-210
        • Woo PCY
        • Fong AHC
        • Ngan AHY
        • et al.
        First reports of Tsukamurella keratitis: association between T. tyrosinosolvens and T. pulmonis and ophthalmic infections.
        J Clin Microbiol. 2009, April 15; ([Epub ahead of print])
        • Elshibly S
        • Doherty J
        • Xu J
        • et al.
        Central line-related bacteraemia due to Tsukamurella tyrosinosolvens in a haematology patient.
        Ulster Med J. 2005; 74: 43-46
        • Sheridan E
        • Warwick S
        • Chan A
        • Dall’Antonia M
        • Koliou M
        • Sefton A
        Tsukamurella tyrosinosolvens intravascular catheter infection identified using 16S ribosomal DNA sequencing.
        Clin Infect Dis. 2003; 36: 69-70
        • Maertens J
        • Wattiau P
        • Verhaegen J
        • Boogaerts M
        • Verbist L
        • Wauters G
        Catheter-related bacteremia due to Tsukamurella pulmonis.
        Clin Microbiol Infect. 1998; 4: 51-53
        • Jones R
        • Fekete T
        • Truant A
        • Satishchandran V
        Persistent bacteremia due to Tsukamurella paurometabolum in a patient undergoing hemodialysis: case report and review.
        Clin Infect Dis. 1994; 18: 830-832
        • Shapiro C
        • Haft R
        • Gantz N
        • et al.
        Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer.
        Clin Infect Dis. 1992; 14: 200-203
        • Clausen C
        • Wallis C
        Bacteremia caused by Tsukamurella species.
        Clin Microbiol Newsletter. 1994; 16: 6-8
        • Stanley T
        • Crothers L
        • McCalmont M
        • et al.
        The potential misidentification of Tsukamurella pulmonis as an atypical Mycobacterium species: a cautionary tale.
        J Med Microbiol. 2006; 55: 475-478
        • de Jesus Perez V
        • Swigris J
        • Ruoss S
        Coexistence of primary adenocarcinoma of the lung and Tsukamurella infection: a case report and review of the literature.
        J Med Case Reports. 2008; 2: 207
        • Almehmi A
        • Pfister A
        • McCowan R
        • Matulis S
        Implantable cardioverter-defibrillator infection caused by Tsukamurella.
        W V Med J. 2004; 100: 185-186
        • Alcaide M
        • Espinoza L
        • Abbo L
        Cavitary pneumonia secondary to Tsukamurella in an AIDS patient. First case and a review of the literature.
        J Infect. 2004; 49: 17-19
        • Shaer A
        • Gadegbeku C
        Tsukamurella peritonitis associated with continuous ambulatory peritoneal dialysis.
        Clin Nephrol. 2001; 56: 241-246
        • Larkin J
        • Lit L
        • Sinnott J
        • Wills T
        • Szentivanyi A
        Infection of a knee prosthesis with Tsukamurella species.
        South Med J. 1999; 92: 831-832
        • Chong Y
        • Lee K
        • Chon C
        • Kim M
        • Kwon O
        • Lee H
        Tsukamurella inchonensis bacteremia in a patient who ingested hydrochloric acid.
        Clin Infect Dis. 1997; 24: 1267-1268
        • Granel F
        • Lozniewski A
        • Barbaud A
        • et al.
        Cutaneous infection caused by Tsukamurella paurometabolum.
        Clin Infect Dis. 1996; 23: 839-840
        • Kwan Kew L
        A cancer patient with central venous catheter-related sepsis caused by Tsukamurella paurometabolum (Gordona aurantiaca).
        Clin Infect Dis. 1993; 17: 285-287
        • Barger A
        • Fuhst C
        • Wiedemann B
        Pharmacological indices in antibiotic therapy.
        J Antimicrob Chemother. 2003; 53: 893-898
        • Forrest A
        • Nix D
        • Ballow C
        • Goss T
        • Birmingham M
        • Schentag J
        Pharmacodynamics of intravenous ciproflaxin in seriously ill patients.
        Antimicrob Agents Chemother. 1993; 37: 1073-1081
        • Mouton J
        Breakpoints: current practice and future perspectives.
        Int J Antimicrob Agents. 2002; 19: 323-331
        • Scaglione F
        Can PK/PD be used in everyday clinical practice.
        Int J Antimicrob Agents. 2002; 19: 349-353
        • Goodman L
        • Gilman A
        The Pharmacological Basis of Therapeutics. 2nd ed. Macmillan, New York, N.Y.2002
        • Jain V
        • Garg P
        • Sharma S
        • Vemuganti G
        Sutureless wound infection by unusual acid-fast organisms.
        Cornea. 2008; 27: 615-618